Reliance Life Sciences is a medical biotechnology-led company engaged in research and development, manufacturing and marketing of differentiated medical products and services, used to treat patients primarily in intensive and critical care units in hospitals. Three core businesses of RLS are plasma proteins, biosimilars, and later generation oncology pharmaceuticals. In addition, it has initiatives in clinical research, molecular medicine, regenerative medicine, genetherapy, peptides and oligonucleotides.